Loading Events

« All Events

  • This event has passed.

SLAS 2021 HCS/HCA Data and Informatics Special Interest Group (SIG)

January 26 @ 10:00 am - 11:00 am

SIG Chair(s)

Shannon Mumenthaler, PhD

Assistant Professor of Medicine
University of Southern California
LOS ANGELES, California, United States

SIG Speaker(s)

Lorna Ewart

Olivier Frey

Head of Technology & Platforms
InSphero AG
Schlieren, Zurich, Switzerland

Seungil Kim

Staff Scientist/Microscopy Team Manager
Lawrence J. Ellison Institute for Transformative Medicine
Los Angeles, California, United States

Title: High content imaging approaches to organs-on-chips: recent advancements and future prospects
Description: Organs-on-chips are miniaturized 3D microfluidic devices that reconstruct the multicellular and physical microenvironment of specific tissues or organs and can be used to model normal or disease level functions. In this SIG, we will discuss: (1) how organs-on-chips recapitulate physiological conditions and offer an alternative or parallel preclinical model to study biological mechanisms or assess drug efficacy/toxicity; (2) high content imaging assays that are being applied to organs-on-chips; and (3) current opportunities, challenges, and development areas for the future of HCS/HCA applications using organs-on-chips platforms.
About the HCS/HCA Data and Informatics Special Interest Group (SIG):
The Data Analysis and Management SIG is dedicated to sharing best practices, experiences and expertise, and to encouraging collaboration. The group will actively address issues in the area of information technology and strategies and foster discussions, information sharing and meetings among group members. This SIG is presented in partnership with the Society of Biomolecular Imaging and Informatics (SBI2).


January 26
10:00 am - 11:00 am
Event Category:



Ellison Institute Insights Forum

The Ellison Institute Insights Forum brings together creative and accomplished thinkers to offer their wisdom on some of the key questions we face in fundamentally understanding and controlling cancer and other complex diseases. Through the Ellison Insights Forum conversations, we will brainstorm solutions for some of the thorniest problems in disease biology, particularly cancer, with equally innovative and transformative ideas.

Next Forum: Thursday, March 11 – Role of Evolution in Cancer Treatment

Last Forum Question: How could applying specific principles of evolution/evolutionary theory (and ecology) across biological and temporal scales of cancer revolutionize treatment strategies, reduce resistance, and improve patient outcomes?

Forum Recording: Click HERE to view the discussion between:

Charles Swanton, MD, PhD – senior group leader of the Cancer Evolution and Genome Instability Laboratory at the Francis Crick Institute, and oncologist at the UCL Cancer Institute

Susan Rosenberg, PhD – Ben F Love Chair in Cancer Research; Professor of Molecular & Human Genetics, Biochemistry & Molecular Biology, and Molecular Virology & Microbiology; and Founder and Leader, Mechanisms in Evolution Program, Dan L Duncan Comprehensive Center, Baylor College of Medicine

Robert Gatenby, MD – Department Chair in Radiology and Co-Director Center of Excellence for Evolution Based Therapy at Moffitt Cancer Center

Kenneth Pienta, MD – Donald S. Coffey Professor of Urology and Professor of Oncology, Pharmacology and Molecular Sciences, and Chemical and Biomolecular Engineering at Johns Hopkins University, ACS Professor and Director of Research for the Brady Urological Institute

Moderated by Anna Barker, PhD, Chief Strategy Officer, Ellison Institute and Distinguished Visiting Fellow in Complex Adaptive Systems, Arizona State University and

David B. Agus, MD, Founding Director & CEO, Ellison Institute and Professor of Medicine & Engineering, USC